X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DR. REDDYS LAB TTK HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 32.9 34.4 95.9% View Chart
P/BV x 6.1 3.4 180.2% View Chart
Dividend Yield % 0.5 0.8 59.7%  

Financials

 TTK HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
DR. REDDYS LAB
Mar-17
TTK HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs6633,397 19.5%   
Low Rs3992,560 15.6%   
Sales per share (Unadj.) Rs535.6856.5 62.5%  
Earnings per share (Unadj.) Rs15.978.0 20.5%  
Cash flow per share (Unadj.) Rs20.0139.9 14.3%  
Dividends per share (Unadj.) Rs4.0020.00 20.0%  
Dividend yield (eoy) %0.80.7 112.1%  
Book value per share (Unadj.) Rs137.6739.8 18.6%  
Shares outstanding (eoy) m7.77165.74 4.7%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.03.5 28.5%   
Avg P/E ratio x33.338.2 87.2%  
P/CF ratio (eoy) x26.521.3 124.6%  
Price / Book Value ratio x3.94.0 95.9%  
Dividend payout %25.125.7 97.8%   
Avg Mkt Cap Rs m4,127493,632 0.8%   
No. of employees `0001.722.7 7.5%   
Total wages/salary Rs m60731,068 2.0%   
Avg. sales/employee Rs Th2,436.76,259.0 38.9%   
Avg. wages/employee Rs Th355.21,369.8 25.9%   
Avg. net profit/employee Rs Th72.5569.7 12.7%   
INCOME DATA
Net Sales Rs m4,162141,961 2.9%  
Other income Rs m611,715 3.6%   
Total revenues Rs m4,223143,676 2.9%   
Gross profit Rs m19724,722 0.8%  
Depreciation Rs m3210,266 0.3%   
Interest Rs m30634 4.7%   
Profit before tax Rs m19715,537 1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0349 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m732,965 2.5%   
Profit after tax Rs m12412,921 1.0%  
Gross profit margin %4.717.4 27.2%  
Effective tax rate %37.019.1 193.9%   
Net profit margin %3.09.1 32.7%  
BALANCE SHEET DATA
Current assets Rs m1,62996,837 1.7%   
Current liabilities Rs m1,05884,199 1.3%   
Net working cap to sales %13.78.9 154.1%  
Current ratio x1.51.2 133.9%  
Inventory Days Days3073 40.6%  
Debtors Days Days3498 34.4%  
Net fixed assets Rs m556102,552 0.5%   
Share capital Rs m78829 9.4%   
"Free" reserves Rs m878121,792 0.7%   
Net worth Rs m1,069122,621 0.9%   
Long term debt Rs m1595,449 2.9%   
Total assets Rs m2,399218,165 1.1%  
Interest coverage x7.625.5 29.7%   
Debt to equity ratio x0.10 334.0%  
Sales to assets ratio x1.70.7 266.6%   
Return on assets %6.46.2 103.2%  
Return on equity %11.610.5 110.0%  
Return on capital %18.512.9 143.1%  
Exports to sales %0.854.6 1.4%   
Imports to sales %1.49.4 15.0%   
Exports (fob) Rs m3377,520 0.0%   
Imports (cif) Rs m5813,274 0.4%   
Fx inflow Rs m3381,670 0.0%   
Fx outflow Rs m6326,355 0.2%   
Net fx Rs m-3055,315 -0.1%   
CASH FLOW
From Operations Rs m12721,444 0.6%  
From Investments Rs m-146-18,404 0.8%  
From Financial Activity Rs m22-3,692 -0.6%  
Net Cashflow Rs m3-1,144 -0.2%  

Share Holding

Indian Promoters % 65.4 25.5 256.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 5.4 68.5%  
FIIs % 5.2 35.3 14.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 25.8 15.3 168.6%  
Shareholders   12,723 75,885 16.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   J.B.CHEMICALS  SUVEN LIFE  STERLING BIOTECH  ELDER PHARMA  ALEMBIC LTD  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ABBOTT INDIA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS